Analyze Diet
Veterinary journal (London, England : 1997)2013; 198(3); 684-689; doi: 10.1016/j.tvjl.2013.09.063

Blood glucose, acid-base and electrolyte changes during loading doses of alpha₂-adrenergic agonists followed by constant rate infusions in horses.

Abstract: The aim of the present study was to investigate changes in blood glucose concentration ([Glu]B), acid-base status and electrolyte concentrations during constant rate infusions (CRI) of two alpha2-adrenergic agonists in seven horses treated in a blinded, randomised, crossover design with xylazine or romifidine. An intravenous (IV) bolus of xylazine (1mg/kg) or romifidine (80 μg/kg) was administered followed by an IV CRI of xylazine (0.69 mg/kg/h) or romifidine (30 μg/kg/h) for 2h. Blood samples were collected from the pulmonary artery before and after loading doses, during the CRI, and for 1h after discontinuing drugs. Blood glucose, base excess (BE), pH, partial pressure of carbon dioxide (Pv¯CO2), strong ion difference (SIDest) and bicarbonate concentration ( [Formula: see text] ) increased significantly during the CRI with both alpha2-adrenergic agonists. Chloride concentration ([Cl(-)]B) and anion-gap (AG) decreased significantly compared to baseline. The decrease in sodium concentration ([Na(+)]B) was only significant with xylazine. From 1h after starting the CRI onwards, [Glu]B was significantly higher with romifidine compared to xylazine. Except [Glu]B, SIDest, and Pv¯CO2, all variables returned to normal values 1h after discontinuing xylazine. After stopping romifidine, all variables except pH remained altered for at least 1h. It was concluded that loading doses of alpha2-adrenergic agonists followed by CRIs produce [Glu]B, acid-base and electrolyte changes. The clinical significance of the reported changes remains to be investigated and absolute values should be interpreted with caution, as fluid boli were used for cardiac output measurements, but may become important during prolonged infusion and in critically ill patients.
Publication Date: 2013-10-04 PubMed ID: 24215780DOI: 10.1016/j.tvjl.2013.09.063Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigated how the use of two alpha2-adrenergic agonists, xylazine and romifidine, in horses affected blood glucose levels, acid-base status, and electrolyte concentrations.

Design of the Study

  • The investigation employed a blinded, randomized, crossover design with seven horses treated either with xylazine or romifidine, both types of alpha2-adrenergic agonists (medications often used for sedation).
  • The horses were first given an intravenous bolus (an amount of substance given all at once rather than gradually) of either xylazine (1mg/kg) or romifidine (80 μg/kg).
  • This was followed by an intravenous constant rate infusion (a stable, ongoing administration of a drug over a certain period of time) of xylazine (0.69 mg/kg/h) or romifidine (30 μg/kg/h) over a span of 2 hours.

Method of Data Collection

  • Blood samples were drawn before and after the loading doses, during the constant rate infusion, and one hour after the drugs had been discontinued.
  • This allowed for a comprehensive timeline of changes in each horse’s blood glucose concentration, base excess (which helps measure the acid-base balance within the body), pH levels, partial pressure of carbon dioxide, strong ion difference (which aids in diagnosing acid-base disorders), bicarbonate concentration, sodium concentration, chloride concentration, and anion-gap (a value calculated from the electrolytes tested in a basic metabolic panel).

Study Results

  • Both drugs were observed to significantly increase blood glucose, base excess, pH levels, partial pressure of carbon dioxide, strong ion difference, and bicarbonate concentration, indicating alterations in the acid-base balance and electrolyte levels of the horses.
  • Chloride concentration and anion-gap decreased notably compared to baseline measurements. The decrease in sodium concentration was considerable only with xylazine.
  • Interestingly, one hour after the start of the constant rate infusion, blood glucose concentration was significantly higher in horses treated with romifidine as opposed to xylazine. Again, one hour after discontinuing the drugs, all variables except for blood glucose concentration, strong ion difference, and partial pressure of carbon dioxide returned to normal values in the case of xylazine. Romifidine, however, caused persistent alterations in all variables except pH for at least 1 hour.

Study Conclusion

  • The researchers concluded that loading doses of alpha2-adrenergic agonists, followed by constant rate infusions, do indeed influence blood glucose concentration, acid-base status, and electrolyte concentrations in horses.
  • The real-world clinical implications of these observed changes remain uncertain and should be interpreted with caution, especially given the use of fluid boli for cardiac output measurements.
  • The importance of these changes may come into play during extended drug infusions and in treatment of critically ill patients where strict control of these factors is vital.

Cite This Article

APA
Ringer SK, Schwarzwald CC, Portier K, Mauch J, Ritter A, Bettschart-Wolfensberger R. (2013). Blood glucose, acid-base and electrolyte changes during loading doses of alpha₂-adrenergic agonists followed by constant rate infusions in horses. Vet J, 198(3), 684-689. https://doi.org/10.1016/j.tvjl.2013.09.063

Publication

ISSN: 1532-2971
NlmUniqueID: 9706281
Country: England
Language: English
Volume: 198
Issue: 3
Pages: 684-689
PII: S1090-0233(13)00505-4

Researcher Affiliations

Ringer, S K
  • Equine Department, Anaesthesiology Section, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland. Electronic address: sringer@vetclinics.uzh.ch.
Schwarzwald, C C
    Portier, K
      Mauch, J
        Ritter, A
          Bettschart-Wolfensberger, R

            MeSH Terms

            • Acid-Base Equilibrium / drug effects
            • Adrenergic alpha-2 Receptor Agonists / administration & dosage
            • Adrenergic alpha-2 Receptor Agonists / pharmacology
            • Animals
            • Blood Glucose / drug effects
            • Cross-Over Studies
            • Electrolytes / metabolism
            • Horses / physiology
            • Imidazoles / administration & dosage
            • Imidazoles / pharmacology
            • Infusions, Intra-Arterial / veterinary
            • Xylazine / administration & dosage
            • Xylazine / pharmacology

            Citations

            This article has been cited 3 times.
            1. Rabbogliatti V, Amari M, Brioschi FA, Di Cesare F, Zani DD, De Zani D, Di Giancamillo M, Cagnardi P, Ravasio G. Use of dexmedetomidine repeated subcutaneous administration for balanced anaesthesia in horses. BMC Vet Res 2022 Jul 11;18(1):269.
              doi: 10.1186/s12917-022-03350-0pubmed: 35818051google scholar: lookup
            2. Ryan A, Gurney M, Steinbacher R. Suspected vagal reflex and hyperkalaemia inducing asystole in an anaesthetised horse. Equine Vet J 2022 Sep;54(5):927-933.
              doi: 10.1111/evj.13535pubmed: 34738246google scholar: lookup
            3. Kritchevsky JE, Muir GS, Leschke DHZ, Hodgson JK, Hess EK, Bertin FR. Blood glucose and insulin concentrations after alpha-2-agonists administration in horses with and without insulin dysregulation. J Vet Intern Med 2020 Mar;34(2):902-908.
              doi: 10.1111/jvim.15747pubmed: 32100334google scholar: lookup